Nutritional assessment and support of the stable COPD patient

Clinical Management of Chronic Obstructive Pulmonary Disease

Volumn , Issue , 2002, Pages 681-701

  Schols, A M W J ^a   Wouters, E F M ^a  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84866991681     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (89)

1. Fowler JS, Volkow ND, Wang GJ, et al. Inhibition of monoamine oxidase B in the brains of smokers. Nature 1996; 379:733–736.
2. Filley GF, Beckwitt HJ, Reever JT, Mitchelli RS. Chronic obstructive bronchopulmonary disease. 2. oxygen transport in two clinical types. Am J Med 1968; 44:26–38.
3. Vandenbergh E, Woestijne VDKP, Gyselen A. Weight changes in the terminal stages of chronic obstructive pulmonary disease. Am Rev Respir Dis 1967; 95:556–566.
4. Wilson DO, Rogers RM, Wright EC, Anthonisen NR. Body weight in chronic obstructive pulmonary disease. The National Institutes of Health Intermittent Positive-Pressure Breathing Trial. Am Rev Respir Dis 1989; 139:1435–1438.
5. Gray Donald K, Gibbons L, Shapiro SH, Macklem PT, Martin JG. Nutritional status and mortality in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1996; 153:961–966.
6. Schols A, Slangen J, Volovics L, Wouters EFM. Weight loss is a reversible factor in the prognosis of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998; 157:1791–1797.
7. Skeletal muscle dysfunction in chronic obstructive pulmonary disease. A statement of the American Thoracic Society and European Respiratory Society. Am J Respir Crit Care Med 1999; 159:S1–40.
8. Engelen J, Schols A, Lamers R, Wouters E. Different patterns of chronic tissue wasting among emphysema and chronic bronchitis patients. Clin Nutr 1999; 18:275–280.
9. Bernard S, LeBlanc P, Whittom F, et al. Peripheral muscle weakness in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998; 158:629–634.
10. Palange P, Forte S, Felli A, Galassetti P, Serra P, Carlone S. Nutritional state and exercise tolerance in patients with COPD. Chest 1995; 107:1206–1212.
11. Palange P, Forte S, Onorati P, et al. Effect of reduced body weight on muscle aerobic capacity in patients with COPD. Chest 1998; 114:12–18.
12. Baarends EM, Schols AM, Mostert R, Wouters EF. Peak exercise response in relation to tissue depletion in patients with chronic obstructive pulmonary disease. Eur Respir J 1997; 10:2807–2813.
13. Russell DM, Walker PM, Leiter LA, et al. Metabolic and structural changes in skeletal muscle during hypocaloric dieting. Am J Clin Nutr 1984; 39:503–513.
14. Layman DK, Merdian Bender M, Hegarty PVJ, Swan PB. Changes in aerobic and anaerobic metabolism in rat cardiac and skeletal muscles after total or partial dietary restrictions. J Nutr 1981; 111:994–1000.
15. Pichard C, Vaughan C, Struk R, Armstrong RL, Jeejeebhoy KN. Effect of dietary manipulations (fasting, hypocaloric feeding, and subsequent refeeding) on rat muscle energetics as assessed by nuclear magnetic resonance spectroscopy. J Clin Invest 1988; 82: 895–901.
16. Bissonnette DJ, Madapallimatam A, Jeejeebhoy KN. Effect of hypoenergetic feeding and high-carbohydrate refeeding on muscle tetanic tension, relaxation rate, and fatigue in slow- and fast-twitch muscles in rats. Am J Clin Nutr 1997; 66:293–303.
17. Rochester DF, Braun NM. Determinants of maximal inspiratory pressure in chronic obstructive pulmonary disease. Am Rev Respir Dis 1985; 132:42–47.
18. Shoup R, Dalsky G, Warner S, et al. Body composition and health-related quality of life in patients with obstructive airways disease. Eur Respir J 1997; 10:1576–1580.
19. Schols AMWJ, Soeters PB, Dingemans AMC, Mostert R, Frantzen PJ, Wouters EFM. Prevalence and characteristics of nutritional depletion in patients with stable COPD eligible for pulmonary rehabilitation. Am Rev Respir Dis 1993; 147:1151–1156.
20. Mostert R, Goris A, Weling-Scheepers C, Wouters E, Schols A. Tissue depletion and health related quality of life in patients with chronic obstructive pulmonary disease. Respir Med 2000; 9:859–867.
21. Pouw E, Ten Velde G, Croonen B, Kester A, Schols A, Wouters E. Early nonelective readmission for chronic obstructive pulmonary disease is associated with weight loss. Clin Nutr. In press.
22. Vitacca M, Clini E, Porta R, Foglio K, Ambrosino N. Acute exacerbations in patients with COPD: predictors of need for mechanical ventilation. Eur Respir J 1996; 9:1487–1493.
23. Beck AM, Ovesen L. At which body mass index and degree of weight loss should hospitalized elderly patients be considered at nutritional risk? Clin Nutr 1998; 17:195–198.
24. Schols A, Wouters EFM, Soeters PB, Westerterp KR. Body composition by bioelectrical- impedance analysis compared with deuterium dilution and skinfold anthropometry in patients with chronic obstructive pulmonary disease. Am J Clin Nutr 1991; 53:421–442.
25. Baarends EM, Schols AMWJ, Van Marken Lichtenbeld WD, Wouters EFM. Analysis of body water compartments in relation to tissue depletion in clinically stable patients with chronic obstructive disease. Am J Clin Nutr 1997; 65:88–94.
26. Engelen MPKJ, Schols AMWJ, Heidendal GAK, Wouters EFM. Dual-energy x-ray absorptiometry in the clinical evaluation of body composition and bone mineral density in patients with chronic obstructive pulmonary disease. Am J Clin Nutr 1998. In press.
27. Engelen MPKJ, Schols AMWJ, Baken WC, Wesseling GJ, Wouters EFM. Nutritional depletion in relation to respiratory and peripheral skeletal muscle function in outpatients with COPD. Eur Respir J 1994; 7:1793–1797.
28. Fiaccadori E, Del Canale S, Coffrini E, et al. Hypercapnic-hypoxemic chronic obstructive pulmonary disease (COPD): influence of severity of COPD on nutritional status. Am J Clin Nutr 1988; 48:680–685.
29. Fitting JW, Frascarolo P, Jequier E, Leuenberger P. Resting energy expenditure in interstitial lung disease. Am Rev Respir Dis 1990; 142:631–635.
30. Schols AM, Fredrix EW, Soeters PB, Westerterp KR, Wouters EF. Resting energy expenditure in patients with chronic obstructive pulmonary disease. Am J Clin Nutr 1991; 54:983–987.
31. Hugli O, Schutz Y, Fitting JW. The cost of breathing in stable chronic obstructive pulmonary disease. Clin Sci Colch 1995; 89:625–632.
32. Sridhar MK, Carter R, Lean MEJ, Banham SW. Resting energy expenditure and nutritional state of patients with increased oxygen cost of breathing due to emphysema, scoliosis and thoracoplasty. Thorax 1994; 49:781–785.
33. Hofford JM, Milakofsky L, Vogel WH, Sacher RS, Savage GJ, Pell S. The nutritional status in advanced emphysema associated with chronic bronchitis A study of amino acid and catecholamine levels. Am Rev Respir Dis 1990; 141:902–908.
34. Wilson SR, Amoroso P, Moxham J, Ponte J. Modification of the thermogenic effect of acutely inhaled salbutamol by chronic inhalation in normal subjects. Thorax 1993; 48: 886–889.
35. Amoroso P, Wilson SR, Moxham J, Ponte J. Acute effects of inhaled salbutamol on the metabolic rate of normal subjects. Thorax 1993; 48:882–885.
36. Creutzberg EC, Schols AM, Bothmer-Quaedvlieg FC, Wesseling G, Wouters EF. Acute effects of nebulized salbutamol on resting energy expenditure in patients with chronic obstructive pulmonary disease and in healthy subjects. Respiration 1998; 65:375–380.
37. De Godoy I, Donahoe M, Calhoun WJ, Mancino J, Rogers RM. Elevated TNF-alpha production by peripheral blood monocytes of weight-losing COPD patients. Am J Respir Crit Care Med 1996; 153:633–637.
38. Di Francia M, Barbier D, Mege JL, Orehek J. Tumor necrosis factor-alpha levels and weight loss in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1994; 150:1453–1455.
39. Takabatake N, Nakamura H, Abe S, et al. Circulating leptin in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999; 159:1215–1219.
40. Schols AMWJ, Buurman WA, Staal van der Brekel AJ, Dentener MA, Wouters EFM. Evidence for a relation between metabolic derangements and elevated inflammatory mediators in a subgroup of patients with chronic obstructive pulmonary disease. Thorax 1996; 51:819–824.
41. Hugli O, Frascarolo P, Schutz Y, Jequier E, Leuenberger P, Fitting JW. Diet-induced thermogenesis in chronic obstructive pulmonary disease. Am Rev Respir Dis 1993; 148: 1479–1483.
42. Baarends EM, Schols AM, Pannemans DL, Westerterp KR, Wouters EF. Total free living energy expenditure in patients with severe chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1997; 155:549–554.
43. Hugli O, Schutz Y, Leuenberger PH, Fitting JW. Twenty-four hour energy expenditure in COPD.
44. Baarends EM, Schols AMWJ, Westerterp KR, Wouters EFM. Total daily energy expenditure relative to resting energy expenditure in clinically stable patients with COPD. Thorax 1997; 52:780–785.
45. Baarends EM, Schols A, Akkermans MA, Wouters EFH. Decreased mechanical efficiency in clinically stable patients with COPD. Thorax 1997; 52:981–986.
46. Wuyam B, Payen JF, Levy P, et al. Metabolism and aerobic capacity of skeletal muscle in chronic respiratory failure related to chronic obstructive pulmonary disease. Eur Respir J 1992; 5:157–162.
47. Maltais F, Simard AA, Simard C, Jobin J, Desgagnes P, LeBlanc P. Oxidative capacity of the skeletal muscle and lactic acid kinetics during exercise in normal subjects and in patients with COPD. Am J Respir Crit Care Med 1996; 153:288–293.
48. Jakobsson P, Jorfeldt L, Henriksson J. Metabolic enzyme activity in the quadriceps femoris muscle in patients with severe chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1995; 151:374–377.
49. Sauleda J, Garcia-Palmer F, Wiesner RJ, et al. Cytochrome oxidase activity and mitochondrial gene expression in skeletal muscle of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998; 157:1413–1417.
50. Engelen M, Schols A, Does J, Deutz N, Wouters E. Altered glutamate metabolism is associated with reduced muscle glutathione levels in patients with emphysema. Am J Respir Crit Care Med 2000; 161:98–103
51. Pouw EM, Schols AMWJ, Vusse VDGJ, Wouters EFM. Elevated iosine monophosphate levels in resting muscle of patients with stable COPD. Am J Respir Crit Care Med 1998; 157:453–457.
52. Pouw EM, Schols AM, Deutz NE, Wouters EF. Plasma and muscle amino acid levels in relation to resting energy expenditure and inflammation in stable chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998; 158:797–801.
53. Goldstein SA, Thomashow BM, Kvetan V, Askanazi J, Kinney JM, Elwyn DH. Nitrogen and energy relationships in malnourished patients with emphysema. Am Rev Respir Dis 1988; 138:636–644.
54. Hjalmarsen A, Aasebo U, Birkeland K, Sager G, Jorde R. Impaired glucose tolerance in patients with chronic hypoxic pulmonary disease. Diab Metab 1996; 22:37–42.
55. Jakobsson P, Jorfeldt L, von Schenck H. Insulin resistance is not exhibited by advanced chronic obstructive pulmonary disease patients. Clin Physiol 1995; 15:547–555.
56. Hunter AMB, Carey MA, Larsh HW. The nutritional status of patients with chronic obstructive pulmonary disease. Am Rev Respir Dis 1981; 124:376–381.
57. Schols AMWJ, Soeters PB, Mostert R, Saris WHM, Wouters EFM. Energy balance in chronic obstructive pulmonary disease. Am Rev Respir Dis 1991;143:1248–1252.
58. Grunfeld C, Zhao C, Fuller J, et al. Endotoxin and cytokines induce expression of leptin, the ob gene product, in hamsters. J Clin Invest 1996; 97:2152–2157.
59. Schols A, Creutzberg E, Buurman W, Campfield L, Saris W, Wouters E. Plasma leptin is related to pro-inflammatory status and dietary intake in patients with COPD. Am J Respir Crit Care Med 1999; 160:1220–1226.
60. Schols AMWJ, Schoffelen PFM, Ceulemans J, Wouters EFM, Saris WHM. Measurement of resting energy expenditure in patients with chronic obstructive pulmonary disease in a clinical setting. J Parent Ent Nutr 1992; 16:364–368.
61. Vermeeren MAP, Schols AMWJ, Quaedvlieg FCM, Wouters EFM. Effects of an acute exacerbation on nutritional and metabolic profile of patients with COPD. Eur Respir J 1997; 10:2264–2269.
62. Creutzberg EC, Schols AMWJ, Bothmer-Quaedvlieg FCM, Wouters EFM. Prevalence of an elevated resting energy expenditure in patients with chronic obstructive pulmonary disease in relation to body composition and lung function. Eur J Clin Nutr 1998; 52: 1–6.
63. Wilson DO, Rogers RM, Sanders MH, Pennock BE, Reilly JJ. Nutritional intervention in malnourished patients with emphysema. Am Rev Respir Dis 1986; 134:672–677.
64. Whittaker JS, Ryan CF, Buckley PA, Road JD. The effects of refeeding on peripheral and respiratory muscle function in malnourished chronic pulmonary disease patients. Am Rev Respir Dis 1990; 142:283–288.
65. Russell DM, Prendergast PJ, Darby PL, Garfinkel PE, Whitwell J, Jeejeebhoy KN. A comparison between muscle function and body composition in anorexia nervosa: the effect of refeeding. Am J Clin Nutr 1983; 38:229–237.
66. Fuenzalida CE, Petty TL, Jones ML, et al. The immune response to short-term nutritional intervention in advanced chronic obstructive pulmonary disease. Am Rev Respir Dis 1990; 142:49–56.
67. Rogers RM, Donahoe M, Constatino J. Physiologic effects of oral supplemental feeding in malnourished patients with chronic obstructive pulmonary diseases, a randomized control study. Am Rev Respir Dis 1992; 146:1511–1517.
68. Efthimiou J, Fleming J, Gomes C, Spiro SG. The effect of supplementary oral nutrition in poorly nourished patients with chronic obstructive pulmonary disease. Am Rev Respir Dis 1988; 137:1075–1082.
69. Otte KE, Ahlburg P, D’Amore F, Stellfeld M. Nutritional repletion in malnourished patients with emphysema. JPEN 1989; 13:152–156.
70. Knowles JB, Fairbarn MS, Wiggs BJ, Chan Yan C, Pardy RL. Dietary supplementation and respiratory muscle performance in patients with COPD. Chest 1988; 93:977–983.
71. Lewis MI, Belman MJ, Dorr Uyemura L. Nutritional supplementation in ambulatory patients with chronic obstructive pulmonary disease. Am Rev Respir Dis 1987; 135: 1062–1067.
72. Donahoe M, Mancino J, Costatino J, Lebow H, Rogers R. The effect of an aggresive support regimen on body composition in patients with severe COPD and weight loss (abstr). Am J Respir Crit Care Med 1994; 149.
73. Schols AMWJ, Soeters PB, Mostert R, Pluymers RJ, Wouters EFM. Physiologic effects of nutritional support and anabolic steroids in patients with chronic obstructive pulmonary disease. A placebo-controlled randomized trial. Am J Respir Crit Care Med 1995; 152:1268–1274.
74. Saudny Unterberger H, Martin JG, Gray Donald K. Impact of nutritional support on functional status during an acute exacerbation of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1997; 156:794–799.
75. Talpers SS, Romberger DJ, Bunce SB, Pingleton SK. Nutritionally associated increased carbon dioxide production Excess total calories vs high proportion of carbohydrate calories. Chest 1992; 102:551–555.
76. Askanazi J, Elwyn DH, Silverberg PA, Rosenbaum SH, Kinney JM. Respiratory distress secondary to a high carbohydrate load: a case report. Surgery 1980; 87:596–598.
77. Efthimiou J, Mounsey PJ, Benson DN, Madgwick R, Coles SJ, Benson MK. Effect of carbohydrate rich versus fat rich loads on gas exchange and walking performance in patients with chronic obstructive lung disease. Thorax 1992; 47:451–456.
78. Frankfort JD, Fischer CE, Stansbury DW, McArthur DL, Brown SE, Light RW. Effects of high- and low-carbohydrate meals on maximum exercise performance in chronic airflow obstruction. Chest 1991; 100:792–795.
79. Akrabawi SS, Mobarhan S, Stoltz RR, Ferguson PW. Gastric emptying, pulmonary function, gas exchange, and respiratory quotient after feeding a moderate versus high fat enteral, formula meal in chronic obstructive pulmonary disease patients, Nutrition 1996; 12:260–265.
80. Vermeeren MAP, Wouters EFM, Nelissen LM, van Lier A, Holman Z, Schols AMWJ. Acute effects of different nutritional supplements as symptoms and functional capacity in patients with chronic obstructive pulmonary disease. Am J Clin Nutr 2001; 3:295–301.
81. Schols AMWJ, Mostert R, Cobben N, Soeters PB, Wouters EFM. Transcutaneous oxygen saturation and carbon dioxide tension during meals in patients with chronic obstructive pulmonary disease. Chest 1991; 100:1287–1292.
82. Morrison WL, Gibson JNA, Scrimgeour C, Rennie MJ. Muscle wasting in emphysema. Clin Sci 1988; 75:415–420.
83. Pouw EM, Schols AM, Deutz NE, Wouters EF. Plasma and muscle amino acid levels in relation to resting energy expenditure and inflammation in stable chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998; 158:797–801.
84. Hopkins B, Bristrian B, Blackburn G. Protein-calorie management in the hospitalized patient. In: Schneider H, ed. Nutritional Support in Clinical Practice. Philadelphia: Harper & Row, 1983.
85. Suchner U, Rothkopf MM, Stanislaus G, Elwyn DH, Kvetan V, Askanazi J. Growth hormone and pulmonary disease. Metabolic effects in patients receiving parenteral nutrition. Arch Intern Med 1990; 150:1225–1230.
86. Pape GS, Friedman M, Underwood LE, Clemmons DR. The effect of growth hormone on weight gain and pulmonary function in patients with chronic obstructive lung disease. Chest 1991; 99:1495–1500.
87. Burdet L, de Muralt B, Schutz Y, Fitting JW. Thermogenic effect of bronchodilators in patients with chronic obstructive pulmonary disease. Thorax 1997; 52:130–135.
88. Ferreira IM, Verreschi IT, Nery LE, et al. The influence of 6 months of oral anabolic steroids on body mass and respiratory muscles in undernourished COPD patients. Chest 1998; 114:19–28.
89. Creutzberg E, Schols A, Weling-Scheepers C, Buurman W, Wouters E. Characterization of non-response to high-caloric oral nutritional therapy in depleted patients with COPD. Am J Respir Crit Care Med 1999.